$379 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 67 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences Inc | $27,724,000 | +10.6% | 402,784 | +3.9% | 7.32% | +10.4% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $25,239,000 | +64.3% | 149,000 | +36.9% | 6.66% | +64.0% |
| SGEN | Buy | SEAGEN INC | $22,868,000 | +23.9% | 145,000 | +9.0% | 6.04% | +23.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $22,274,000 | – | 237,873 | +100.0% | 5.88% | – |
| REGN | Sell | Regeneron Pharmaceuticals | $20,778,000 | +0.3% | 37,200 | -15.1% | 5.49% | +0.1% |
| NBIX | Neurocrine Biosciences Inc | $20,127,000 | +0.0% | 207,000 | 0.0% | 5.31% | -0.2% | |
| PTCT | Buy | PTC Therapuetics COM | $18,948,000 | -1.9% | 449,000 | +10.0% | 5.00% | -2.1% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $17,113,000 | +41.9% | 176,400 | 0.0% | 4.52% | +41.7% | |
| BIIB | Biogen Inc | $16,794,000 | +23.8% | 48,500 | 0.0% | 4.43% | +23.5% | |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $13,069,000 | -28.7% | 64,822 | -24.0% | 3.45% | -28.8% |
| AMGN | Buy | Amgen Inc | $12,431,000 | +16.2% | 51,000 | +18.6% | 3.28% | +16.0% |
| INCY | Buy | Incyte Corp | $11,509,000 | +81.6% | 136,860 | +75.5% | 3.04% | +81.2% |
| QURE | Buy | UNIQURE NV | $9,705,000 | +2.3% | 315,500 | +11.9% | 2.56% | +2.1% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $9,481,000 | +23.0% | 121,541 | +49.1% | 2.50% | +22.7% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $7,768,000 | +74.6% | 43,300 | +62.8% | 2.05% | +74.3% |
| XLRN | ACCELERON PHARMA INC | $7,592,000 | -7.4% | 60,500 | 0.0% | 2.00% | -7.6% | |
| IONS | Sell | Ionis Pharmaceuticals Inc | $7,251,000 | -51.7% | 181,781 | -45.5% | 1.91% | -51.8% |
| PTGX | PROTAGONIST THERAPEUTICS INC | $6,813,000 | +73.1% | 152,000 | 0.0% | 1.80% | +72.8% | |
| KALV | Buy | Kalvista Pharmaceuticals Inc | $6,786,000 | +23.7% | 283,233 | +32.0% | 1.79% | +23.5% |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $6,233,000 | – | 202,436 | +100.0% | 1.65% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $5,731,000 | +150.8% | 60,100 | +199.0% | 1.51% | +150.5% |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $4,686,000 | – | 166,000 | +100.0% | 1.24% | – |
| BMRN | Biomarin Pharmaceutical Inc | $4,602,000 | +10.5% | 55,156 | 0.0% | 1.22% | +10.3% | |
| CCXI | Sell | CRISPR THERAPEUTICS AGnamen akt | $4,043,000 | -72.6% | 58,100 | -79.9% | 1.07% | -72.7% |
| AUPH | AURINIA PHARMACEUTICALS INC | $3,869,000 | -0.2% | 298,500 | 0.0% | 1.02% | -0.4% | |
| HALO | Buy | Halozyme Therapeutics Inc | $3,752,000 | +159.8% | 82,633 | +138.6% | 0.99% | +159.4% |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $3,661,000 | -18.4% | 100,000 | 0.0% | 0.97% | -18.5% | |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $3,553,000 | – | 20,000 | +100.0% | 0.94% | – |
| ITCI | INTRA CELLULAR THERAPIES INC | $3,243,000 | +20.1% | 79,456 | 0.0% | 0.86% | +19.9% | |
| INSM | Buy | INSMED INC | $2,849,000 | +149.0% | 100,100 | +197.9% | 0.75% | +148.2% |
| DYN | Buy | DYNE THERAPEUTICS INC | $2,840,000 | +95.5% | 135,000 | +43.8% | 0.75% | +95.3% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $2,730,000 | -76.3% | 16,900 | -74.9% | 0.72% | -76.4% |
| HCM | New | HUTCHMED CHINA LTDsponsored ads | $2,671,000 | – | 68,000 | +100.0% | 0.70% | – |
| STRO | SUTRO BIOPHARMA INC | $2,590,000 | -18.3% | 139,331 | 0.0% | 0.68% | -18.5% | |
| SRPT | Sarepta Therapeutics Inc | $2,450,000 | +4.3% | 31,500 | 0.0% | 0.65% | +4.2% | |
| KDNY | New | CHINOOK THERAPEUTICS INC | $2,412,000 | – | 170,821 | +100.0% | 0.64% | – |
| ZLAB | New | ZAI LAB LTDadr | $2,264,000 | – | 12,800 | +100.0% | 0.60% | – |
| NKTX | New | NKARTA INC | $2,214,000 | – | 70,000 | +100.0% | 0.58% | – |
| GH | New | GUARDANT HEALTH INC | $2,112,000 | – | 17,000 | +100.0% | 0.56% | – |
| EXEL | Sell | Exelixis Inc | $1,850,000 | -90.8% | 101,534 | -88.5% | 0.49% | -90.8% |
| ASND | Ascendis Pharma ASsponsored adr | $1,815,000 | +2.3% | 13,800 | 0.0% | 0.48% | +2.1% | |
| BPMC | Blueprint Medicines Corp | $1,715,000 | -9.5% | 19,500 | 0.0% | 0.45% | -9.6% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $1,509,000 | -17.8% | 58,000 | 0.0% | 0.40% | -18.1% | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $1,498,000 | – | 34,047 | +100.0% | 0.40% | – |
| APLS | APELLIS PHARMACEUTICALS INCcm | $1,476,000 | +47.5% | 23,400 | 0.0% | 0.39% | +47.2% | |
| ARNA | Arena Pharmaceuticals Inc | $1,431,000 | -1.8% | 21,000 | 0.0% | 0.38% | -1.8% | |
| ALLK | ALLAKOS INC | $1,338,000 | -25.7% | 15,700 | 0.0% | 0.35% | -25.8% | |
| EXAS | Exact Sciences Corp | $1,328,000 | -5.8% | 10,700 | 0.0% | 0.35% | -5.9% | |
| AGIO | Agios Pharmaceuticals Inc | $1,185,000 | +6.9% | 21,500 | 0.0% | 0.31% | +6.8% | |
| NKTR | NEKTAR THERAPEUTICS | $1,149,000 | -14.3% | 67,000 | 0.0% | 0.30% | -14.4% | |
| ALKS | New | ALKERMES PLC | $1,103,000 | – | 45,000 | +100.0% | 0.29% | – |
| AXSM | AXSOME THERAPEUTICS INC | $944,000 | +19.0% | 14,000 | 0.0% | 0.25% | +18.6% | |
| ORIC | ORIC PHARMACEUTICALS INC | $938,000 | -27.7% | 53,000 | 0.0% | 0.25% | -27.7% | |
| FOLD | Amicus Therapeutics Inc | $912,000 | -2.5% | 94,600 | 0.0% | 0.24% | -2.4% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $763,000 | -14.1% | 21,800 | 0.0% | 0.20% | -14.5% | |
| GMDA | GAMIDA CELL LTD | $682,000 | -20.9% | 107,000 | 0.0% | 0.18% | -21.1% | |
| IMVT | New | IMMUNOVANT INC | $634,000 | – | 60,000 | +100.0% | 0.17% | – |
| ARDX | New | ARDELYX INC | $591,000 | – | 78,000 | +100.0% | 0.16% | – |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $535,000 | – | 44,000 | +100.0% | 0.14% | – |
| FGEN | FibroGen Inc | $525,000 | -23.2% | 19,700 | 0.0% | 0.14% | -23.2% | |
| IMAB | Sell | I MABsponsored ads | $503,000 | -70.3% | 6,000 | -82.9% | 0.13% | -70.3% |
| XENE | New | XENON PHARMACEUTICALS INC | $474,000 | – | 25,500 | +100.0% | 0.12% | – |
| BLUE | Bluebird Bio Inc | $351,000 | +5.7% | 11,000 | 0.0% | 0.09% | +5.7% | |
| TVTX | TRAVERE THERAPEUTICS INC | $292,000 | -41.5% | 20,000 | 0.0% | 0.08% | -41.7% | |
| ANAB | ANAPTYSBIO INC | $259,000 | +19.9% | 10,000 | 0.0% | 0.07% | +19.3% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $201,000 | -24.4% | 9,500 | 0.0% | 0.05% | -24.3% | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -59,514 | -100.0% | -0.41% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -21,500 | -100.0% | -0.43% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -22,000 | -100.0% | -0.71% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -16,300 | -100.0% | -1.66% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB LTD | $0 | – | -393,000 | -100.0% | -9.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.